ClinicalTrials.govpublic full text
Combo of Cabozantinib With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic CRPC
prostate cancer, castration resistant prostate cancer, prostatic neoplasms, crpc, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 807092
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.